XTL Biopharmaceuticals Ltd (XTLB)
1.83
+0.06
(+3.39%)
USD |
NASDAQ |
Nov 21, 16:00
1.67
-0.16
(-8.74%)
Pre-Market: 20:00
XTL Biopharmaceuticals Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2013 | 0.00 |
| September 30, 2013 | 0.00 |
| June 30, 2013 | 0.00 |
| March 31, 2013 | 0.00 |
| December 31, 2012 | 0.00 |
| September 30, 2012 | 0.00 |
| June 30, 2012 | 0.00 |
| March 31, 2012 | 0.00 |
| December 31, 2011 | 0.00 |
| September 30, 2011 | 0.00 |
| June 30, 2011 | 0.00 |
| March 31, 2011 | 0.00 |
| December 31, 2010 | 0.00 |
| September 30, 2010 | 0.00 |
| June 30, 2010 | 0.00 |
| March 31, 2010 | 0.00 |
| December 31, 2009 | 0.00 |
| September 30, 2009 | 0.00 |
| June 30, 2009 | |
| March 31, 2009 |
| Date | Value |
|---|---|
| December 31, 2008 | 0.00 |
| September 30, 2008 | |
| June 30, 2008 | 0.00 |
| March 31, 2008 | |
| December 31, 2007 | 0.00 |
| September 30, 2007 | |
| June 30, 2007 | 0.00 |
| March 31, 2007 | |
| December 31, 2006 | 0.00 |
| September 30, 2006 | |
| June 30, 2006 | 0.00 |
| March 31, 2006 | |
| December 31, 2005 | 0.00 |
| September 30, 2005 | |
| June 30, 2005 | 0.00 |
| March 31, 2005 | |
| December 31, 2004 | 0.00 |
| September 30, 2004 | |
| June 30, 2004 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Compugen Ltd | 0.00 |
| Pluri Inc | -4.801 |
| BioLine Rx Ltd | 2.106 |
| Can Fite Biofarma Ltd | 0.00 |
| BiomX Inc | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 2.928M |
| Total Liabilities (Quarterly) | 0.223M |
| Shareholders Equity (Quarterly) | 2.705M |